Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Fibrosing Interstitial Lung Diseases”

50 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 50 results

Testing effectiveness (Phase 2)Ended earlyNCT02615938
What this trial is testing

Hydroxychloroquine (HCQ) in Pediatric Interstitial Lung Disease (ILD)

Who this might be right for
Interstitial Lung DiseaseDiffuse Parenchymal Lung DiseaseChildren´s Interstitial Lung Disease
Matthias Griese 35
Large-scale testing (Phase 3)Study completedNCT05321082
What this trial is testing

Find Out Whether BI 1015550 Improves Lung Function in People With Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)

Who this might be right for
Lung Diseases, Interstitial
Boehringer Ingelheim 1,178
Testing effectiveness (Phase 2)Active Not RecruitingNCT06329401
What this trial is testing

A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis

Who this might be right for
Pulmonary FibrosisProgressive Pulmonary FibrosisPulmonary Fibrosis Secondary to Systemic Sclerosis+7 more
Avalyn Pharma Inc. 375
Not applicableUnknownNCT05372926
What this trial is testing

Physiological Effects of HFNC During Exercise in Patients With Fibrosing Interstitial Lung Diseases

Who this might be right for
Interstitial Lung DiseasePulmonary Rehabilitation
ADIR Association 16
Testing effectiveness (Phase 2)Looking for participantsNCT05139719
What this trial is testing

Explore the Therapeutic Effect of HEC585 on Delaying Forced Vital Capacity (FVC) Decline and Tolerance in Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Patients

Who this might be right for
Progressive Fibrosing Interstitial Lung Disease (PF-ILD) / Progressive Pulmonary Fibrosis (PPF)
Sunshine Lake Pharma Co., Ltd. 110
Not applicableStudy completedNCT05492994
What this trial is testing

Test Different Imaging Techniques in Patients With Different Types of Interstitial Lung Disease

Who this might be right for
Lung Diseases, Interstitial
Boehringer Ingelheim 31
Large-scale testing (Phase 3)Looking for participantsNCT07366034
What this trial is testing

Find Out How Nerandomilast is Tolerated, Handled by the Body, and if it Helps Children and Adolescents With Interstitial Lung Disease (FIBRONEER-chILD)

Who this might be right for
Fibrosing Interstitial Lung Disease
Boehringer Ingelheim 35
Testing effectiveness (Phase 2)Study completedNCT04308681
What this trial is testing

A Study Measuring the Effectiveness, Safety, and Tolerability of BMS-986278 in Participants With Lung Fibrosis

Who this might be right for
Pulmonary Fibrosis
Bristol-Myers Squibb 403
Not applicableStudy completedNCT05227443
What this trial is testing

Effects of Exercise Training on Respiratory Performance in Patients With Fibrosing Interstitial Lung Diseases

Who this might be right for
Lung DiseasesInterstitial Lung DiseaseFibrosis Lung
Alexandria University 31
Not applicableStudy completedNCT04857814
What this trial is testing

Integrating Electronic Patient Reported Biometric Measures (ePReBMs) From Wearable Devices in Respiratory Diseases

Who this might be right for
Progressive Fibrosing Interstitial Lung DiseaseLung TransplantCystic Fibrosis+2 more
University of Alberta 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT06422884
What this trial is testing

Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)

Who this might be right for
Idiopathic Pulmonary FibrosisProgressive Fibrosing Interstitial Lung Disease
Endeavor Biomedicines, Inc. 213
Testing effectiveness (Phase 2)Study completedNCT03099187
What this trial is testing

Pirfenidone in Patients With Unclassifiable Progressive Fibrosing Interstitial Lung Disease

Who this might be right for
Lung Diseases, Interstitial
Hoffmann-La Roche 253
Not applicableActive Not RecruitingNCT05914506
What this trial is testing

Hyperpolarized 129-Xenon MRI in Fibrosing Interstitial Lung Disease

Who this might be right for
Progressive Fibrosing Interstitial Lung Disease
University of Aarhus 30
Not applicableUnknownNCT05988437
What this trial is testing

Contribution of the Indoor Environment Medical Advisor in the Management of Fibrosing Hypersensitivity Pneumonitis

Who this might be right for
Hypersensitivity Pneumonitis
Nantes University Hospital 100
Not applicableUnknownNCT06527612
What this trial is testing

The Effect of Exercise Training on Quality of Life and Disease Progression in Fibrosing Interstitial Lung Patients

Who this might be right for
Fibrosis, PulmonaryPulmonary Rehabilitation
Istanbul Medipol University Hospital 56
Not applicableUnknownNCT05450276
What this trial is testing

Patient-Reported Outcome Study of Project ECHO for ILD

Who this might be right for
Interstitial Lung Disease
Pulmonary Care and Research Collaborative Limited 56
Not applicableEnded earlyNCT05503030
What this trial is testing

Correlation Between Changes in Lung Function and Changes in Cough and Dyspnoea in Nintedanib-treated Connective Tissue Disease Interstitial Lung Disease (CTD-ILD) Patients

Who this might be right for
Lung Diseases, Interstitial
Boehringer Ingelheim 88
Large-scale testing (Phase 3)Study completedNCT03820726
What this trial is testing

A Follow-up Study Investigating Long Term Treatment With Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)

Who this might be right for
Lung Diseases, Interstitial
Boehringer Ingelheim 435
Not applicableUnknownNCT05445817
What this trial is testing

Pulmonary Care and Research Collaborative Patient Registry

Who this might be right for
Interstitial Lung Disease
Pulmonary Care and Research Collaborative Limited 150
Not applicableStudy completedNCT05166057
What this trial is testing

Telerehabilitation in Patients With Fibrosing Interstitial Lung Diseases

Who this might be right for
Fibrosing Interstitial Lung DiseaseTelerehabilitation
Saglik Bilimleri Universitesi 63
Next Page